These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7903534)

  • 1. Biochemical characterization of a mitomycin C resistant colon cancer cell line variant.
    Perry RR; Kang Y; Greaves B
    Biochem Pharmacol; 1993 Dec; 46(11):1999-2005. PubMed ID: 7903534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and initial characterization of a mitomycin C-resistant colon cancer cell line variant.
    Perry RR; Greaves BR; Kang Y
    Cancer Chemother Pharmacol; 1993; 32(4):326-8. PubMed ID: 8324877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute and chronic intermittent hypoxia on DNA topoisomerase II alpha expression and mitomycin C-induced DNA damage and cytotoxicity in human colon cancer cells.
    Kang Y; Greaves B; Perry RR
    Biochem Pharmacol; 1996 Aug; 52(4):669-76. PubMed ID: 8759040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH; Naito M; Nakajima M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
    Pan SS; Akman SA; Forrest GL; Hipsher C; Johnson R
    Cancer Chemother Pharmacol; 1992; 31(1):23-31. PubMed ID: 1458556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
    Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine.
    Ruiz-Gómez MJ; Souviron A; Martínez-Morillo M; Gil L
    J Physiol Biochem; 2000 Dec; 56(4):307-12. PubMed ID: 11321524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C.
    Hoban PR; Robson CN; Davies SM; Hall AG; Cattan AR; Hickson ID; Harris AL
    Biochem Pharmacol; 1992 Feb; 43(4):685-93. PubMed ID: 1311588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
    Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH; Gupta V; Singh SV
    Int J Cancer; 1994 Sep; 58(5):686-92. PubMed ID: 8077054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
    Geng M; Wang L; Chen X; Cao R; Li P
    Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV; Xu BH; Maurya AK; Mian AM
    Biochim Biophys Acta; 1992 Nov; 1137(3):257-63. PubMed ID: 1445927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory network of mitomycin C action in human colon cancer cells.
    Suzuki K; Yamamoto W; Park JS; Hanaoka H; Okamoto R; Kirihara Y; Yorishima T; Okamura T; Kumazaki T; Nishiyama M
    Jpn J Cancer Res; 1999 May; 90(5):571-7. PubMed ID: 10391098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.
    Kuzmich S; Vanderveer LA; Walsh ES; LaCreta FP; Tew KD
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):219-24. PubMed ID: 1731759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR; Greaves BR; Rasberry U; Barranco SC
    Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.